ITM-23

N/A

Report date: 2025/11/21 17:16:24

Base Information

Drug NameITM-23

Drug Alias NameITM-23161Tb- ITM23

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Terbium > 161TbRadiation-emitting products > Radionuclide Drug Conjugates

Mechanisms of ActionIonising radiation emittersRadionuclide imaging enhancersProstate-Specific Membrane Antigen modulators

TargetsProstate-Specific Membrane Antigen

Therapy Area/IndicationsProstatic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesItm Solucin Gmbh

China Registration ClassN/A

Develop Information

Active CompaniesItm Solucin Gmbh

Inactive CompaniesN/A

Active IndicationsProstatic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A